wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36550838-36CAA2A0-E58D-4DC0-8D8A-8A4AB15B3DFB
Q36550838-36CAA2A0-E58D-4DC0-8D8A-8A4AB15B3DFB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36550838-36CAA2A0-E58D-4DC0-8D8A-8A4AB15B3DFB
Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Relapsing on Standard Dose Alectinib.
P2860
Q36550838-36CAA2A0-E58D-4DC0-8D8A-8A4AB15B3DFB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36550838-36CAA2A0-E58D-4DC0-8D8A-8A4AB15B3DFB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2635d00451dbb625a7cbc1521c692783d92e29d9
P2860
Next-generation sequencing reveals a Novel NSCLC ALK F1174V mutation and confirms ALK G1202R mutation confers high-level resistance to alectinib (CH5424802/RO5424802) in ALK-rearranged NSCLC patients who progressed on crizotinib.